Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

101.16
Delayed Data
As of 10:25am ET
 -0.72 / -0.71%
Today’s Change
76.11
Today|||52-Week Range
114.91
-10.49%
Year-to-Date
FBT Regular Dividend: FBT began trading ex-dividend on 09/21/16. A $0.00 dividend will be paid to shareholders of record as of 09/23/16.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

Inside the Recent Surge in Biotech ETFs
Sep 14 / Zacks.com - Paid Partner Content
 

Performance

1 month+0.63% 3 years+16.25%
3 months+11.42% 5 years+24.40%
1 year-8.94% Since inception+17.34%
Data through 09/24/2016

Quote Details

Previous close$101.88
Open day’s range101.00 – 101.63
Net asset value (NAV)101.87 (09/23/2016)
Daily volume7,257
Average volume (3 months)84,703
Data as of 10:25am ET, 09/26/2016

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+24.40%+15.32%
Expense Gross exp ratio0.55%0.48%
Risk 5 year sharpe ratio0.921.16
Net assets$843.8M$1.1B
Average market cap$9.2B$37.2B
Average P/E--20.2
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MDVN Medivation Inc4.23%
-- 3.92%
BIIB Biogen3.82%
NKTR Nektar Therapeutics3.76%
ILMN Illumina Inc3.68%
UTHR United Therapeutics Corp3.59%
IONS Ionis Pharmaceuticals Inc3.53%
ALNY Alnylam Pharmaceuticals Inc3.52%
Q Quintiles Transnational Holdings Inc3.51%
REGN Regeneron Pharmaceuticals3.42%

Search for Jobs